Meeting
2024 ASCO Genitourinary Cancers Symposium
Homologous recombination repair (HRR) alterations may be passenger events in patients with advanced prostate cancer (PC) with high tumor mutational burden (hTMB).
Authors
Vineel Bhatlapenumarthi
Department of Medicine, Division of Hematology and Oncology, The Medical College of Wisconsin, Milwaukee, WI
Vineel Bhatlapenumarthi , Navonil De Sarkar , Anannya Patwari , Emmanuel S. Antonarakis , Ariel Ann Nelson , Deepak Kilari
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 206)
DOI
10.1200/JCO.2024.42.4_suppl.206
Abstract #
206
Poster Bd #
J14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Single and multi-hit PIK3CA short variant (SV) genomic alterations (GA) in clinically advanced prostate cancer (CAPC): A genomic landscape study.
First Author: Carla Miguel
Poster
2023 ASCO Genitourinary Cancers Symposium
Use of a navigable interface for integrated whole genome and transcriptome sequencing as a platform for pursuit of therapeutic targets in advanced prostate cancers.
First Author: Jones T. Nauseef
Poster
2022 ASCO Genitourinary Cancers Symposium
Genomic classification of clinically advanced major genito-urinary cancers (GUca) based on methylthioadenosine phosphorylase (MTAP) genomic loss.
First Author: Philippe E. Spiess
Poster
2022 ASCO Genitourinary Cancers Symposium
Identification of homologous recombination and repair (HRR) deficiency using circulating tumor DNA (ctDNA) in advanced prostate cancer (aPC).
First Author: Leslie A. Bucheit